Explore how Cathepsin B-cleavable cyclopeptidic prodrugs act as molecular Trojan horses to deliver chemotherapy precisely to cancer cells, reducing side effects.
Discover how glycan-based paclitaxel prodrugs target cancer cells through glucose transporters for more precise chemotherapy with fewer side effects.
Exploring how ruthenium complexes are emerging as promising alternatives to platinum-based cancer therapies with improved targeting and reduced side effects.
Exploring how metal-containing macromolecules are revolutionizing cancer treatment with targeted therapy and reduced side effects.
Discover how Anisina, a first-in-class drug targeting cancer's cytoskeleton, enhances chemotherapy effectiveness by 20-fold in neuroblastoma treatment.